Baird Adjusts HealthEquity Price Target to $ 53 From $ 86, Maintains Neutral Rating

0


MT 2021 press wires

All news on HEALTHEQUITY, INC.

Analyst Recommendations on HEALTHEQUITY, INC.
Sales 2022 753 million

Net income 2022 -13.2 million

Net cash 2022 782 million

PER 2022 ratio -370x
Yield 2022
Capitalization 4,737 M
4,737 M
VE / Sales 2022 5.25x
VE / Sales 2023 4.65x
Number of employees 3,020
Free float 98.2%

Chart HEALTHEQUITY, INC.
Duration :

Period:

HealthEquity, Inc. Technical Analysis Chart |  MarketScreener

Technical Analysis Trends HEALTHEQUITY, INC.

Short term Mid Road Long term
Tendencies Bearish Bearish Bearish

Evolution of the income statement

To sell

To buy

Average consensus TO BUY
Number of analysts 12
Last closing price

$ 56.67

Average price target

$ 77.11

Spread / Average target 36.1%


Share.

About Author

Comments are closed.